Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
Chaps
Nicole A
NA
D000329:Advertising / Q000331:legislation & jurisprudence; D002017:Budgets / Q000331:legislation & jurisprudence; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence; D003256:Community Participation / Q000331:legislation & jurisprudence; D018795:Device Approval / Q000331:legislation & jurisprudence*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004348:Drug Labeling / Q000331:legislation & jurisprudence; D004869:Equipment Safety; D004864:Equipment and Supplies; D035082:Federal Government; D033161:Government Regulation; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology; D007252:Influenza Vaccines; D020407:Internet / Q000331:legislation & jurisprudence; D007880:Legislation, Drug; D056687:Off-Label Use / Q000331:legislation & jurisprudence; D053918:Papillomavirus Vaccines; D011356:Product Labeling / Q000331:legislation & jurisprudence; D013219:State Government; D019460:Tobacco Industry / Q000331:legislation & jurisprudence*; D014481:United States; D014486:United States Food and Drug Administration / Q000191:economics / Q000331:legislation & jurisprudence*
D007252:Influenza Vaccines; D053918:Papillomavirus Vaccines